AKT1S1

AKT1 substrate 1, the group of MTOR complex 1

Basic information

Region (hg38): 19:49869033-49878459

Links

ENSG00000204673NCBI:84335OMIM:610221HGNC:28426Uniprot:Q96B36AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AKT1S1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AKT1S1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
clinvar
4
missense
30
clinvar
1
clinvar
31
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 30 3 2

Variants in AKT1S1

This is a list of pathogenic ClinVar variants found in the AKT1S1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-49869930-T-C not specified Uncertain significance (Sep 27, 2021)2252473
19-49869933-A-T not specified Uncertain significance (Nov 20, 2023)3108258
19-49869953-G-C not specified Uncertain significance (Jun 29, 2023)2607416
19-49869964-G-A not specified Uncertain significance (Mar 20, 2024)3283134
19-49869976-C-G not specified Uncertain significance (Oct 13, 2023)3108250
19-49869986-C-A not specified Uncertain significance (May 09, 2023)2511790
19-49871584-C-G not specified Uncertain significance (Sep 14, 2021)2248990
19-49871665-G-T not specified Uncertain significance (Mar 29, 2023)2557372
19-49871695-G-T not specified Uncertain significance (Sep 20, 2024)3519213
19-49871844-G-C not specified Uncertain significance (Mar 18, 2024)3283117
19-49871866-C-T not specified Likely benign (Dec 19, 2023)3108230
19-49871884-A-T not specified Uncertain significance (Oct 18, 2021)2391995
19-49872931-A-G not specified Uncertain significance (Mar 20, 2024)3283126
19-49872948-G-A Benign (Oct 10, 2018)716506
19-49872952-G-T not specified Uncertain significance (Mar 16, 2022)2278802
19-49872955-T-C not specified Uncertain significance (Mar 25, 2024)3283106
19-49872977-C-T not specified Uncertain significance (Dec 06, 2023)3108219
19-49873060-G-A not specified Uncertain significance (Feb 17, 2024)3108215
19-49873070-G-A not specified Uncertain significance (Dec 07, 2024)2227925
19-49873070-G-C not specified Uncertain significance (Aug 27, 2024)3519232
19-49873106-C-T not specified Uncertain significance (Dec 28, 2022)2340255
19-49873118-G-A not specified Uncertain significance (Jun 26, 2024)3519222
19-49873131-C-T Benign (Jul 16, 2018)713406
19-49873132-G-A not specified Uncertain significance (Jun 21, 2023)2596692
19-49873150-T-C not specified Uncertain significance (Aug 02, 2021)2399801

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AKT1S1protein_codingprotein_codingENST00000391835 59422
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1110.863125736061257420.0000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6421341570.8560.000009951686
Missense in Polyphen4770.4530.66711810
Synonymous0.7126370.60.8920.00000490603
Loss of Function1.9139.290.3234.60e-7109

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006190.0000615
Ashkenazi Jewish0.000.00
East Asian0.0001640.000163
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.0001640.000163
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Subunit of mTORC1, which regulates cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino acids. Growth factor-stimulated mTORC1 activation involves a AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase that potently activates the protein kinase activity of mTORC1. Amino acid-signaling to mTORC1 requires its relocalization to the lysosomes mediated by the Ragulator complex and the Rag GTPases. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-389', which then promotes protein synthesis by phosphorylating PDCD4 and targeting it for degradation. Within mTORC1, AKT1S1 negatively regulates mTOR activity in a manner that is dependent on its phosphorylation state and binding to 14-3-3 proteins. Inhibits RHEB-GTP-dependent mTORC1 activation. Substrate for AKT1 phosphorylation, but can also be activated by AKT1-independent mechanisms. May also play a role in nerve growth factor-mediated neuroprotection. {ECO:0000269|PubMed:16174443, ECO:0000269|PubMed:17277771, ECO:0000269|PubMed:17386266}.;
Pathway
mTOR signaling pathway - Homo sapiens (human);Longevity regulating pathway - multiple species - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Longevity regulating pathway - Homo sapiens (human);Target Of Rapamycin (TOR) Signaling;VEGFA-VEGFR2 Signaling Pathway;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Steatosis AOP;Pathways in clear cell renal cell carcinoma;Senescence and Autophagy in Cancer;Disease;Signal Transduction;HSF1-dependent transactivation;Cellular responses to stress;mTORC1-mediated signalling;mTOR signalling;insulin Mam;Cellular responses to external stimuli;PIP3 activates AKT signaling;Cellular response to heat stress;Constitutive Signaling by AKT1 E17K in Cancer;PI3K/AKT Signaling in Cancer;AKT phosphorylates targets in the cytosol;Intracellular signaling by second messengers;mTOR signaling pathway;Diseases of signal transduction;Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met);LKB1 signaling events (Consensus)

Recessive Scores

pRec
0.214

Intolerance Scores

loftool
0.503
rvis_EVS
-0.2
rvis_percentile_EVS
38.82

Haploinsufficiency Scores

pHI
0.234
hipred
Y
hipred_score
0.640
ghis
0.561

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.992

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Akt1s1
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Gene ontology

Biological process
negative regulation of protein kinase activity;negative regulation of TOR signaling;regulation of apoptotic process;regulation of neuron apoptotic process;negative regulation of cell size;neurotrophin TRK receptor signaling pathway;regulation of cellular response to heat
Cellular component
nucleoplasm;cytoplasm;cytosol;TORC1 complex
Molecular function
protein binding